
Vitamin D supplementation reduces relapse or death risk in p53-immunoreactive digestive tract cancer patients.


coremsg

New data reveal that vitamin D supplementation in a subgroup of patients with digestive tract cancer who are p53-immunoreactive may reduce their risk of relapse or death.

'Game Changer' Data for Vitamin D in Digestive Tract Cancers

vitamin-d-impact-on-digestive-tract-cancer-outcomes


Vitamin D Impact on Digestive Tract Cancer Outcomes
